Periodic Reporting for period 1 - EPINuc (Single-Molecule Epigenetic Analysis of Plasma Isolated Nucleosomes for Colon Cancer Diagnostics)
Periodo di rendicontazione: 2021-03-01 al 2022-08-31
The analysis of cell-free DNA (cfDNA) in plasma represents a rapidly advancing field in medicine, providing information on pathological processes in the body. Blood cfDNA is in the form of nucleosomes, which maintain their tissue- and cancer-specific epigenetic state. We developed EPINUC, a single-molecule multi-parametric assay to comprehensively profile the Epigenetics of Plasma Isolated Nucleosomes, DNA methylation and cancer-specific protein biomarkers. Our system allows high-resolution detection of six active and repressive histone modifications, their ratios and combinatorial patterns, on millions of individual nucleosomes by single-molecule imaging. In addition, it provides sensitive and quantitative data on plasma proteins, including detection of non-secreted tumor-specific proteins such as mutant p53. Applying EPINUC analysis to a cohort of 63 colorectal cancer, 10 pancreatic cancer, and 33 healthy plasma samples detected cancer at high accuracy and sensitivity, even at early stages. Finally, combining EPINUC with direct single-molecule DNA sequencing revealed the tissue-of-origin of colorectal, pancreatic, lung and breast tumors. EPINUC provides multi-layered clinical-relevant information from limited (<1ml) liquid biopsy material, establishing a novel approach for cancer diagnostics.